Skip to content

Screening of new plasma miRNA diagnostic markers for liver cancer

Screening of new plasma miRNA diagnostic markers for liver cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061201
Enrollment
Unknown
Registered
2022-06-15
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cancer

Interventions

Gold Standard:Chinese Society of Clinical Oncology Liver Cancer Diagnostic Criteria
Index test:miRNA

Sponsors

The Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Liver cancer: (1) Patients with liver cancer diagnosed by imaging and serological examination; (2) Newly diagnosed patients who have not received any relevant treatment before; (3) Informed consent; (4) Age: 18 years old or above (adult); 2. Liver cirrhosis: (1) Clinically diagnosed as liver cirrhosis; (2) Informed consent; (3) Age: 18 years old or above (adult).

Exclusion criteria

Exclusion criteria: 1. Liver cancer: (1) Combined with other malignant tumors; (2) Metastatic liver tumors; (3) Accompanied by major organic disease; (4) Acute complications such as acute liver failure and gastrointestinal hemorrhage; 2. Liver cirrhosis: (1) Accompanied by major organic disease; (2) Acute complications such as acute liver failure and gastrointestinal bleeding.

Design outcomes

Primary

MeasureTime frame
miRNA level;

Countries

China

Contacts

Public ContactZhou Zhihang

The Second Affiliated Hospital of Chongqing Medical University

zhouzhihang@cqmu.edu.cn+86 17815183428

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026